Clinical Trials in Minneapolis

Showing 2121-2140 of 6,957 trials

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

NCT03533517

This is a non-randomized, prospective, multi-center Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF).

Heart FailureCardiomyopathy, Dilated

Ancora Heart, Inc.22 participantsStarted Aug 2018

San Francisco, California, United States • Atlanta, Georgia, United States • Louisville, Kentucky, United States +15 more locations

COMPLETEDPhase 2< 1 mile

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

NCT04466098

This is a multi-center, randomized, placebo controlled, interventional phase 2A trial to evaluate the safety profile and potential efficacy of multi-dosing of mesenchymal stromal cells (MSC) for patients with SARS-CoV-2 associated Acute Respiratory Distress Syndrome (ARDS). After informed consent, treatment assignment will be made by computer-generated randomization to administer either MSC or vehicle placebo control with a 2:1 allocation to the MSC: placebo arm.

Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia

Masonic Cancer Center, University of Minnesota8 participantsStarted Jul 2020

Minneapolis, Minnesota, United States • Pittsburgh, Pennsylvania, United States

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Find Trials by Condition in Minneapolis

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

Study of Nerve Repair and Reconstruction Associated With Major Extremity Trauma

Novel Experimental COVID-19 Therapies Affecting Host Response

Acupuncture in Traumatic Brain Injury

Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML

Plasma Resuscitation Without Lung Injury